论文部分内容阅读
Background: Ischemia-reperfusion (IR) induced acute kidney injury (AKI) is the common clinical syndrome.Stem/progenitor cells therapy is a promising option to foster the intrinsic capacity of renal regeneration.However,several challenges still remain due to the potential risks during in vitro cell culture,low retention rate after transplantation and unclear effect on the progression of chronic kidney disease (CKD).